Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study

Publication | Closed Access

DOI

115

Citations

References

2013

Year

Kaoru Kubota, Toyoaki Hida, Satoshi Ishikura, Junki Mizusawa, Makoto Nishio, Masaaki Kawahara, Akira Yokoyama, Fumio Imamura, Koji Takeda, Shunichi Negoro,

The Lancet Oncology

Radiation TherapyMedicineRandomised Phase 3Thoracic RadiotherapyCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences